Advanced search
Publication Cover
Leukemia & Lymphoma Volume 43, 2002 - Issue 3
Submit an article Journal homepage
180
Views
39
CrossRef citations to date
0
Altmetric
Research Article

Bone Morphogenetic Protein (BMP)-2 Induces Apoptosis in Human Myeloma Cells

Chiharu Kawamura Division of Hematology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan
,
Masahiro Kizaki Division of Hematology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan
&
Yasuo Ikeda Division of Hematology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan
Pages 635-639 | Published online: 01 Jul 2009

  • Bataille, R. and Harousseu, J-L. (1997) "Multiple myeloma", N. Engl. J. Med. 336, 1657-1664.
  • Hogan, B.L.M. (1996) "Bone morphogenetic protein: multifunctional regulators of vertebrate development", Genes Dev. 10, 1580-1594.
  • Rosen, V. and Thies, R.S. (1992) "The BMP proteins in bone formation and repair", Trends Genet. 8, 97-102.
  • Urist, M.R. (1965) "Bone: formation by autoinduction", Science 150, 893-899.
  • Wozney, J.M., Rosen, V., Celeste, A.J., Mitsock, L.M., Whitters, M.J., Kriz, R.W., Hewick, R.M. and Wang, E.A. (1988) "Novel regulators of bone formation: molecular clones and activities", Science 242, 1528-1534.
  • Urist, M.R. and Strates, B.S. (1971) "Bone morphogenetic protein", J. Dent. Res. 50, 1392-1406.
  • Reddi, H. (1994) "Bone and cartilage differentiation", Curr. Opin. Genet. Dev. 4, 737-744.
  • Yokouchi, Y., Sakiyama, J., Katmeda, T., Iba, H., Suzuki, A., Ueno, N. and Kuroiwa, A. (1996) "BMP-2/-4 mediate programmed cell death in chicken limb buds", Development 122, 3725-3734.
  • Iwasaki, S., Iguchi, M., Watanabe, K., Hoshino, R., Tsujimoto, M. and Kuhno, M. (1999) "Specific activation of the p38 mitogenactivated protein kinase signaling pathway and induction of neurite outgrowth in PCI2 cells by bone morphogenetic protein-2", J. Biol. Chem. 274, 26503-26510.
  • Bhatia, M., Bonnet, D., Wu, D., Murdoch, B., Wrana, J., Gallacher, L. and Dick, J.E. (1999) "Bone morphogenetic proteins regulate the developmental program of human hematopoietic stem cells", J. Exp. Med. 189, 1139-1147.
  • Zhang, H. and Bradley, A. (1996) "Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development", Development 122, 2977-2996.
  • Maeno, M., Mead, P.E., Kelley, C., Xu, R.H., Kung, H.F., Suzuki, A., Ueno, N. and Zon, L.I. (1996) "The role of BMP-4 and GATA-2 in the induction and differentiation of hematopoietic musoderm in Xenopus laevis", Blood 88, 1965-1972.
  • Huber, T.L., Zhou, Y., Mead, P.E. and Zon, L.I. (1998) "Cooperative effects of growth factors involved in the induction of hematopoietic mesoderm", Blood 92, 4128-4137.
  • Johansson, B.M. and Wiles, M.V. (1995) "Evidence for involvement of activin A and bone morphogenetic protein 4 in mammalian mesoderm and hematopoietic development", Mol. Cell. Biol. 15, 141-151.
  • Detmer, K., Steele, T.A., Shoop, M.A. and Dannawi, H. (1999) "Lineage-restricted expression of bone morphogenetic protein genes in human hematopoietic cell lines", Blood Cells Mol. Dis. 25, 310-323.
  • Kawamura, C., Kizaki, M., Yamato, K., Uchida, H., Fukuchi, Y., Hattori, Y. Koseki, T., Nishihara, T. and Ikeda, Y. (2000) "Bone morphogenetic protein-2 induces apoptosis in human myeloma cells with modulation of STAT3", Blood 96, 2005-2011.
  • ten Dijke, P., Miyazono, K. and Heldin, C.H. (1996) "Signaling via hetero-oligomeric complexes of type I and type II serine/threonine kinase receptors", Curr. Opin. Cell Biol. 8, 139-145.
  • Heldin, C.H., Miyazono, K. and ten Dijke, P. (1997) "TGF-ß signaling from cell membrane to nucleus through SMAD proteins", Nature 390, 465-471.
  • Kawabata, M., Imamura, T. and Miyazono, K. (1998) "Signal transduction by bone morphogenetic proteins", Cytokine Growth Factor Rev 9, 49-61.
  • Massague, J. (1998) "TGF-ß signal transduction", Ann. Rev. Biochem. 67, 753-791.
  • Imamura, T., Takase, M., Nishihara, A., Oeda, E., Hanai, J., Kawabata, M. and Miyazono, K (1997) "Smad6 inhibits signalling by the TGF-beta superfamily", Nature 389, 622-626.
  • Hahn, S.A., Schutte, M., Hoque, AT., Moskaluk, C.A., da Costa, L.T., Rozenblum, E., Weinstein, C.L., Fischer, A., Yeo, C.J., Hruban, R.H. and Kern. S.E. (1996) "DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1", Science 271, 350-353.
  • Eppert, K., Scherer, S.W., Ozcelik, H., Pirone, R., Hoodless, P., Kim, H., Tsui, L.C., Bapat, B., Gallinger, S., Andrulis, I.L., Thomsen, G.H., Wrana, J.L. and Attisano, L. (1996) "MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma", Cell 86, 543-552.
  • Hata, A., Shi, Y. and Massague, J. (1998) "TGF-beta signaling and cancer: structural and functional consequences of mutations in Smads", Mol. Med. Today 4, 257-262.
  • Xu, J. and Attisano, L. (2000) "Mutations in the tumor suppressors Smad2 and Smad4 inactive transforming growth factor beta signaling by targeting Smads to the ubiquitin-proteasome pathway", Proc. Natl. Acad. Sci. USA 97, 4820-4825.
  • Imai, Y., Kurokawa, M., Izutsu, K., Hangaishi, A., Maki, K., Ogawa, S., Chiba, S., Mitani, K. and Hirai, H. (2001) "Mutations of the Smad4 gene in acute myelogeneous leukemia and their functional implications in leukemogenesis", Oncogene 20, 88-96.
  • Moriguchi, T., Kuroyanagi, N., Yamaguchi, K., Gotoh, Y., Irie, K., Kano, T., Shirakabe, K., Muro, Y, Shibuya, H., Matsumoto, K., Nishida, E. and Hagiwara, M. (1996) "A novel kinase cascade mediated by mitogen-activated protein kinase kinase 6 and MKK3", J. Biol. Chem. 271, 13675-13679.
  • Shibuya, H., Iwata, H., Masuyama, N., Gotoh, Y., Yamaguchi, K., Irie, K., Matsumoto, K., Nishida, E. and Ueno, N. (1998) "Role of TAK1 and TAB1 in BMP signaling in early Xenopus development", EMBO J. 17, 1019-1028.
  • Yamaguchi, K., Nagai, S., Ninomiya-Tsuji, J., Nishita, M., Tamai, K., Irie, K., Ueno, N., Nishida, E., Shibuya, H. and Matsumoto, K. (1999) "XIAP, a cellular member of the inhibitor of apoptosis protein family, links the receptors to TABl-TAKl in the BMP signaling pathway", EMBO J. 18, 179-187.
  • Hanafusa, H., Ninomiya-Tsuji, J., Masuyama, N., Nishita, M., Fujisawa, J., Shibuya, H., Matsumoto, K. and Nishida, E. (1999) "Involvement of the p38 mitogen-activated protein kinase pathway in transforming growth factor-ß-induced gene expression", J. Biol. Chem. 274, 27161-27167.
  • Ishisaki, A., Yamato, K., Hashimoto, S., Nakao, A., Tamaki, K., Nonaka, K., ten Dijke, P., Sugino, H. and Nishihara, T. (1999) "Differential inhibition of Smad6 and Smad7 on bone morphogenetic protein- and activin-mediated growth arrest and apoptosis in B cells", J. Biol. Chem. 274, 13637-13642.
  • Yamato, K., Hashimoto, S., Okahashi, N., Ishisaki, A., Nonaka, K., Koseki, T, Kizaki, M., Ikeda, Y. and Nishihara, T. (2000) "Dissociation of bone morphogenetic protein-mediated growth arrest and apoptosis of mouse B cells by HPV-16 E6/E7", Exp. Cell Res. 257, 198-205.
  • Yamato, K., Hashimoto, S., Imamura, T., Uchida, H., Okahashi, N., Koseki, T. Ishisaki, A., Kizaki, M., Miyazono, K., Ikeda, Y. and Nishihara, T. (2001) "Activation of the p21CIP/WAF1 promoter by bone morphogenetic protein-2 in mouse B lineage cells", Oncogene, 20,4383-4392.
  • Kimura, N., Matsuo, R. Shibuya, H., Nakashima, K. and Taga, T. (2000) "BMP2-induced apoptosis is mediated by activation of the TAK1-p38 kinase pathway that is negatively regulated by Smad6", J Biol. Chem. 275, 17647-17652.
  • Kawano, M., Hirano, T., Matsuda, T., Taga, T., Horii, Y., Iwato, K., Asaoku, H., Tang, B., Tenabe, O. and Tanaka, H. (1988) "Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas", Nature 332, 83-85.
  • Klein, B., Zhang, X.G., Yang, L.Z. and Bataille, R. (1995) "Interleukin-6 in human multiple myeloma", Blood 85, 863-872.
  • Lichitenstein, A., Tu, Y., Fady, C., Vescio, R. and Berenson, J. (1995) "Interleukin-6 inhibits apoptosis of malignant plasma cells", Cell Immunol. 162, 248-255.
  • Chauhan, D., Kharbanda, S., Ogata, A., Urashima, M., Teoh, G., Robertson, M., Kufe, D.W. and Anderson, K.C. (1997) "Interleukin-6 inhibits Fas-induced apoptosis and SAP kinase activation in multiple myeloma cells", Blood 89, 227-234.
  • Hibi, M., Nakajima, K. and Hirano, T. (1996) "IL-6 cytokine family and signal transduction a model of the cytokine system", J. Mol. Med. 74, 1-12.
  • Ihle, J.N. (1996) "STATs. Signal transducers and activators of transcription", Cell 84, 331-334.
  • Fukada, T., Hibi, M. Yamanaka, Y., Takahashi-Tezuka, M., Fujitani, Y., Yamaguchi, T., Nakajima, K. and Hirano, T. (1996) "Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: Involvement of STAT3 in anti-apoptosis", Immunity 5, 449-460.
  • Bromberg, J.F., Wrzeszczynska, M.H., Devgan, G., Zhao, Y., Pestell, R.G., Albanese, C. and Darnell, Jr., J.E. (1999) "STAT3 as an oncogene", Cell 98, 295-303.
  • Takeda, K., Kaisho, T., Yoshida, N., Takeda, J., Kishimoto, T. and Akira, S. (1998) "Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: generation and characterization of T cell-specific Stat3-deficient mice", J. Immunol. 161, 4652-4660.
  • Catlett-Falcone, R., Laadowski, T.H., Oshiro, M.M., Turkson, J., Levitzki, A., Savino, R., Ciliberto, G., Moscinski, L., Fernandez-Luna, J.L., Nunez, G., Dalton, W.S. and Jove, R. (1999) "Constitutive activation of STAT3 signaling confers resistance to apoptosis in human U266 myeloma cells", Immunity 10, 105-115.
  • Hjertner, O., Hjorth-Hansen, H., Borset, M., Seidel, C., Waage, A. and Sundan, A. (2001) "Bone morphogenetic protein-4 inhibits proliferation and induces apoptosis of multiple myeloma cells", Blood 97, 516-522.
  • Bataille, R., Chappard, D. and Klein, B. (1992) "Mechanisms of bone lesions in multiple myeloma", Hematol. Oncol. Clin. N. 6, 285-295.
  • Namikawa, R., Ueda, R. and Kyoizumi, S. (1993) "Growth of human myeloid leukemias in the human marrow environment of SCID-hu mice", Blood 82, 2526-2536.
  • Yaccoby, S. and Epstein, J. (1999) "The proliferative potential of myeloma plasma cells manifest in the SCID-hu host", Blood 94, 3576-3582.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.